Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity owenhaskins Apr 18, 2024 3 min read Eli Lilly and Company has announced positive topline results from the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide injection (10mg or 15mg) significantly reduced the apnoea-hypopnea index (AHI) compared to placebo, achieving the primary endpoints
Weight-loss alternative medications, like Wegovy, are more likely to be given to patients who are not showing signs of weight-loss with proper diet, exercise, and healthy lifestyle habits
Many of the substances named in the announcement have been explored for their potential roles in areas like tissue repair, immune modulation, metabolic function, and cognitive health
According to the rules laid down by Nobel in his 1895 will, the prizes can only honor up to three people per award a growing challenge given the collaborative nature of much scientific research
Ozempics manufacturer recommends promptly telling your provider if you develop any of those symptoms
However, patients taking these medications should monitor for hypoglycemia symptoms if their tirzepatide dosing interval changes